ARQL - ArQule Inc.
Previous close
20
0 0%
Share volume: 0
Last Updated: Wed 15 Jan 2020 06:00:00 AM CET
Pharmaceuticals: Other:
0%
PREVIOUS CLOSE
CHG
CHG%
$20.00
0.00
0.00%
Summary score
24%
Profitability
36%
Dept financing
14%
Liquidity
23%
Performance
15%
Sector
Health Technology
Industry
Pharmaceuticals: Other
Long-term ratios 30-Sep-2015 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-26.35%
Return on assets
-11.28%
Return on sales
0%
Return on invested capital
65.12%
Total debt ratio
36.77%
Debt ratio change over timeo
-0.59%
Current Ratio
6.16%
Quick Ratio
0%
Cash Position Ratio
2.34%
Short-term ratios 30-Sep-2018 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-9.46%
Return on assets
-7.46%
Return on sales
0%
Return on invested capital
51%
Total debt ratio
20.64%
Debt ratio change over timeo
-0.73%
Current Ratio
8.64%
Quick Ratio
0%
Cash Position Ratio
3.18%
Last quarter ratios 30-Sep-2019
The data are presented for the financials results of the last quarter.
Return on equity
-7.01%
Return on assets
-6.25%
Return on sales
0%
Return on invested capital
-29.16%
Total debt ratio
15.09%
Debt ratio change over time
-0.85%
Current Ratio
8.27%
Quick Ratio
0%
Cash Position Ratio
2.73%
Performance ratios (change over 4 years) 30-Sep-2015 - 30-Sep-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-129.84%
Return on assets
-113.09%
Return on sales
0%
Return on invested capital
-35.25%
Total debt ratio
-59.24%
Debt ratio change over time
-0.59%
Current Ratio
4.9%
Quick Ratio
0%
Cash Position Ratio
1.65%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ARQL | MYOK | MDCO | PTLA |
|---|---|---|---|---|
| Return on equity | -26.35% | -5.44% | -82.7% | -903.99% |
| Return on assets | -11.28% | -4.95% | -6.39% | -17.23% |
| Return on sales | 0% | 0% | -592.81% | -952.03% |
| Return on invested capital | 65.12% | -114.84% | -39.78% | -54.62% |
| Profitability | 50% | 50% | 0% | 0% |
| Total debt ratio | 36.77% | 15.38% | 89.22% | 57.3% |
| Debt ratio change over time | -0.59% | -0.98% | -8.16% | -0.77% |
| Dept financing | 35% | 4% | 25% | 16% |
| Current Ratio | 8.64% | 14.79% | 3.97% | 4.86% |
| Quick Ratio | 0% | 0% | 4.55% | 4.81% |
| Cash Position Ratio | 3.18% | 11.85% | 3.22% | 2.72% |
| Liquididy | 27% | 50% | 27% | 53% |
| Short-term ratios | ARQL | MYOK | MDCO | PTLA |
|---|---|---|---|---|
| Return on equity | -9.46% | -5.63% | 59.24% | -2857.58% |
| Return on assets | -7.46% | -5.77% | -5.09% | -16.26% |
| Return on sales | 0% | 0% | 0% | -308.47% |
| Return on invested capital | 51% | -95.26% | -20.57% | 250.44% |
| Profitability | 30% | 0% | 50% | 25% |
| Total debt ratio | 20.64% | 6.35% | 103.58% | 82% |
| Debt ratio change over time | -0.73% | -1.07% | -10.63% | -0.72% |
| Dept financing | 5% | 2% | 25% | 45% |
| Current Ratio | 8.64% | 14.79% | 3.97% | 4.86% |
| Quick Ratio | 0% | 0% | 4.55% | 4.81% |
| Cash Position Ratio | 3.18% | 11.85% | 3.22% | 2.72% |
| Liquididy | 21% | 50% | 37% | 39% |